Blair William & CO Aptinyx Inc. Transaction History

Blair William & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$2.27 - $3.62 $1,589 - $2,534	700 Added 3.65%	19,877 $45,000
Q4 2021 Feb 14, 2022	BUY	$2.11 - $3.0 $40,463 - $57,531	19,177 New	19,177 $51,000
Q1 2019 May 14, 2019	SELL	$3.99 - $19.33 $107,331 - $519,976	-26,900 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$19.83 - $24.17 $533,427 - $650,173	26,900 New	26,900 $650,000

Ticker APTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,715,696
Description
Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic pe...

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

Stay updated on Blair William & CO with notifications on news.